Sintx Technologies, Inc. (NASDAQ:SINT) Short Interest Down 36.2% in June

Sintx Technologies, Inc. (NASDAQ:SINT) was the target of a significant decrease in short interest in the month of June. As of June 15th, there was short interest totaling 124,886 shares, a decrease of 36.2% from the May 31st total of 195,626 shares. Currently, 3.0% of the shares of the company are sold short. Based on an average daily volume of 100,500 shares, the short-interest ratio is currently 1.2 days.

Sintx Technologies Stock Up 0.8%

Shares of SINT traded up $0.01 during mid-day trading on Thursday, reaching $1.89. The company had a trading volume of 10,490 shares, compared to its average volume of 42,564. The stock has a market capitalization of $8.14 million, a P/E ratio of -0.37 and a beta of 0.63. Sintx Technologies has a 52-week low of $1.80 and a 52-week high of $6.78. The stock has a 50 day moving average of $2.21 and a two-hundred day moving average of $2.79.

Sintx Technologies (NASDAQ:SINT) last announced its quarterly earnings results on Friday, May 15th. The company reported ($0.70) earnings per share for the quarter, missing the consensus estimate of ($0.66) by ($0.04). The company had revenue of $0.38 million for the quarter, compared to analysts’ expectations of $0.30 million. Sintx Technologies had a negative net margin of 1,058.60% and a negative return on equity of 366.49%. On average, sell-side analysts expect that Sintx Technologies will post -2.22 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on SINT shares. HC Wainwright reiterated a “buy” rating and issued a $10.00 target price on shares of Sintx Technologies in a research report on Wednesday, May 20th. Maxim Group restated a “buy” rating and set a $6.00 price objective on shares of Sintx Technologies in a research note on Thursday, June 4th. Ascendiant Capital Markets dropped their price objective on shares of Sintx Technologies from $16.00 to $12.00 and set a “buy” rating on the stock in a report on Wednesday, April 8th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Sintx Technologies in a research note on Tuesday, April 21st. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $9.33.

Institutional Inflows and Outflows

A hedge fund recently raised its position in Sintx Technologies stock. Geode Capital Management LLC lifted its position in shares of Sintx Technologies, Inc. (NASDAQ:SINT) by 33.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,339 shares of the company’s stock after acquiring an additional 3,848 shares during the quarter. Geode Capital Management LLC owned 0.56% of Sintx Technologies worth $49,000 as of its most recent SEC filing. 18.38% of the stock is owned by institutional investors and hedge funds.

Sintx Technologies Company Profile

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.